Skip to main content


Health Photos

Novartis says that it now seeks approval for serelaxin. Researchers say that in a study of 1,161 patients, the drug cut deaths from any cause at six months by 37 percent and led to a marked reduction in worsening of heart failure during hospitalization.
909 of 1896



Newsletter Sign Up



Daily Readings

Reading 1, Joel 2:12-18
'But now -- declares Yahweh- come back to me with all your ... Read More

Psalm, Psalms 51:3-4, 5-6, 12-13, 14, 17
For I am well aware of my offences, my sin is constantly in ... Read More

Gospel, Matthew 6:1-6, 16-18
'Be careful not to parade your uprightness in public to attract ... Read More

Reading 2, Second Corinthians 5:20--6:2
So we are ambassadors for Christ; it is as though God were ... Read More

Saint of the Day

February 10 Saint of the Day

St. Scholastica
February 10: St. Scholastica, sister of St. Benedict, consecrated her life to ... Read More